These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38837000)

  • 21. Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study.
    Zwiers AJ; de Wildt SN; van Rosmalen J; de Rijke YB; Buijs EA; Tibboel D; Cransberg K
    Crit Care; 2015 Apr; 19(1):181. PubMed ID: 25895828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.
    Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients.
    Matsa R; Ashley E; Sharma V; Walden AP; Keating L
    Crit Care; 2014 Jul; 18(4):R137. PubMed ID: 24985156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.
    Gunnerson KJ; Shaw AD; Chawla LS; Bihorac A; Al-Khafaji A; Kashani K; Lissauer M; Shi J; Walker MG; Kellum JA;
    J Trauma Acute Care Surg; 2016 Feb; 80(2):243-9. PubMed ID: 26816218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.
    Daubin D; Cristol JP; Dupuy AM; Kuster N; Besnard N; Platon L; Buzançais A; Brunot V; Garnier F; Jonquet O; Klouche K
    PLoS One; 2017; 12(1):e0169674. PubMed ID: 28085896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.
    Meersch M; Schmidt C; Van Aken H; Martens S; Rossaint J; Singbartl K; Görlich D; Kellum JA; Zarbock A
    PLoS One; 2014; 9(3):e93460. PubMed ID: 24675717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7.
    Yang HS; Hur M; Lee KR; Kim H; Kim HY; Kim JW; Chua MT; Kuan WS; Chua HR; Kitiyakara C; Phattharapornjaroen P; Chittamma A; Werayachankul T; Anandh U; Herath S; Endre Z; Horvath AR; Antonini P; Di Somma S;
    Ann Lab Med; 2022 Mar; 42(2):178-187. PubMed ID: 34635611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Urinary NGAL as a Diagnostic Tool for Acute Kidney Injury in Critically Ill Patients With Infection: An Original Study.
    Gomes BC; Silva Júnior JM; Tuon FF
    Can J Kidney Health Dis; 2020; 7():2054358120934215. PubMed ID: 32612844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of patients' clinical features at intensive care unit admission on performance of cell cycle arrest biomarkers in predicting acute kidney injury.
    Yang B; Xie Y; Garzotto F; Ankawi G; Passannante A; Brendolan A; Bonato R; Carta M; Giavarina D; Vidal E; Gregori D; Ronco C
    Clin Chem Lab Med; 2020 Sep; 59(2):333-342. PubMed ID: 32986608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.
    Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA;
    J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
    Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
    Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
    Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
    Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of acute kidney injury and the role of urinary [TIMP-2]·[IGFBP7]: a prospective cohort study in critically ill obstetric patients.
    Tyagi A; Luthra A; Kumar M; Das S
    Int J Obstet Anesth; 2018 Nov; 36():77-84. PubMed ID: 30245258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Will urinary biomarkers provide a breakthrough in diagnosing cardiac surgery-associated AKI? - A systematic review.
    Hussain ML; Hamid PF; Chakane N
    Biomarkers; 2020 Jul; 25(5):375-383. PubMed ID: 32479185
    [No Abstract]   [Full Text] [Related]  

  • 36. Interest of Urinary [TIMP-2] × [IGFBP-7] for Predicting the Occurrence of Acute Kidney Injury After Cardiac Surgery: A Gray Zone Approach.
    Finge T; Bertran S; Roger C; Candela D; Pereira B; Scott C; Muller L; Louart B; Lefrant JY
    Anesth Analg; 2017 Sep; 125(3):762-769. PubMed ID: 28537976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.
    Schanz M; Wasser C; Allgaeuer S; Schricker S; Dippon J; Alscher MD; Kimmel M
    Nephrol Dial Transplant; 2019 Nov; 34(11):1902-1909. PubMed ID: 29961888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children.
    Bai Z; Fang F; Xu Z; Lu C; Wang X; Chen J; Pan J; Wang J; Li Y
    BMC Pediatr; 2018 Jun; 18(1):192. PubMed ID: 29907141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tubular injury and cell-cycle arrest biomarkers to predict acute kidney injury in noncritically ill children receiving aminoglycosides.
    Chui H; Caldwell J; Yordanova M; Cockovski V; Fredric D; Harel-Sterling M; Haasz M; Al-Ismaili Z; Pizzi M; Ma Q; Devarajan P; Goldstein SL; Zappitelli M
    Biomark Med; 2020 Jul; 14(10):879-894. PubMed ID: 32808826
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.
    Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T
    PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.